Markets Shrug Off Semi Weakness…And One Biopharma Stock Surges After Trial Results 6/24/24
Publisher |
CNBC
Media Type |
audio
Categories Via RSS |
Business
Investing
News
Publication Date |
Jun 24, 2024
Episode Duration |
00:43:40

Nvidia notching another day of losses, but the broader markets aren’t taking it too hard. How investors are handling the semi slide. Plus A big jump for one biopharma stock as Alnylam delivers promising new heart drug results. What the CEO had to say about the data, and the impact it could have on the space.

 

Fast Money Disclaimer

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review